<code id='C46AED55FA'></code><style id='C46AED55FA'></style>
    • <acronym id='C46AED55FA'></acronym>
      <center id='C46AED55FA'><center id='C46AED55FA'><tfoot id='C46AED55FA'></tfoot></center><abbr id='C46AED55FA'><dir id='C46AED55FA'><tfoot id='C46AED55FA'></tfoot><noframes id='C46AED55FA'>

    • <optgroup id='C46AED55FA'><strike id='C46AED55FA'><sup id='C46AED55FA'></sup></strike><code id='C46AED55FA'></code></optgroup>
        1. <b id='C46AED55FA'><label id='C46AED55FA'><select id='C46AED55FA'><dt id='C46AED55FA'><span id='C46AED55FA'></span></dt></select></label></b><u id='C46AED55FA'></u>
          <i id='C46AED55FA'><strike id='C46AED55FA'><tt id='C46AED55FA'><pre id='C46AED55FA'></pre></tt></strike></i>

          Home / entertainment / explore

          explore


          explore

          author:Wikipedia    Page View:6
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In